Pharmacist Check-Ins may cut cancer Patients' emergency trips
NCT ID NCT06469957
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a hospital pharmacist's interview could reduce unplanned doctor visits or hospital stays for adults with lung cancer receiving chemotherapy, immunotherapy, or oral targeted therapy. Researchers tracked 60 patients over six months, counting unscheduled consultations and hospitalizations. The goal was to see if pharmacist involvement improves medication management and reduces disruptions in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU d'Orléans
Orléans, 45067, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.